Componente activoPlantas medicinales

Mulberry Leaf (Kuwa)

桑の葉 (Kuwa-no-ha)

Por qué hacer sourcing en Japón

Japanese historic sericulture infrastructure repurposed for kuwa-cha and supplement extract; FFC notifications support metabolic-health retail positioning.

Spec clave

Deoxynojirimycin (DNJ) 0.1-0.3% in dried leaf; chlorogenic acid 1-3%; rutin 0.5-2%; quercetin glycosides.

Producto final típico

Kuwa-cha (mulberry-leaf tea), blood-sugar-support FFC supplements, Kampo-positioned wellness products.

At a glance

Proveedores listados
3 proveedores
MOQ típico
10–50 kg dried leaf; 1–10 kg standardised extract
Plazo típico
6–10 weeks
Regiones de origen
Nagano, Gunma, Kumamoto, Iwate
Categoría
Plantas medicinales
Temporada de cosecha
May – September (multiple harvests per year)
Estado regulatorio en Japón
FFC notifications exist (post-meal blood-sugar moderation); food product status
Nombre INCI
Morus Alba Leaf Extract
Nombre japonés
桑の葉
Romaji
Kuwa-no-ha

Sobre este ingrediente

Mulberry leaf (Morus alba) — a Kampo herbal raw material with FFC notifications referencing post-meal blood-sugar moderation, anchored in the leaf's deoxynojirimycin (DNJ) content. Japanese cultivation, historically tied to the silk industry, has been re-purposed for kuwa-cha (mulberry-leaf tea) and DNJ-standardised supplement extracts. Nagano (the historic silk region), Gunma, and Kumamoto produce commercial supply; small-volume specialty producers in mountainous Tōhoku also contribute. Distinct from the existing mushroom and bamboo-leaf functional entries.

Estado regulatorio

JapónFFC notifications exist (post-meal blood-sugar moderation); food product status
Unión EuropeaNovel Food consideration; CosIng comparable for cosmetic extract
Estados UnidosDSHEA NDI for supplements; GRAS by traditional use
ChinaNMPA / TCM context; well-precedented import

Proveedores japoneses

Consultar sobre Mulberry Leaf (Kuwa)